Sponsor:
Oana Danciu
Code:
NCT05467891
Conditions
Locoregional Recurrence
Hormone Receptor-positive Breast Cancer
HER2-negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ribociclib
Fulvestrant
Anastrozole
Letrozole
Exemestane
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations